#HostDirectedTherapy
LightNews LightNews
in-armor.bsky.social
🚀 This achievement strengthens the integration of nanotechnology, drug development and biological validation within the IN-ARMOR pipeline, supporting the progression of selected candidates towards preclinical evaluation.

#HostDirectedTherapy #DrugDelivery
In Armor Project - In Armor Project
THERAPEUTIC EPIGENETIC ENHANCEMENT OF INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESISTANCE THERAPEUTIC EPIGENETIC ENHANCEMENT OF INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESISTANC...
inarmor-project.eu
September 24, 2026 at 7:54 AM
in-armor.bsky.social
New milestone achieved!

The consortium has completed the advanced characterisation of its selected lead compounds for host-directed therapies (HDTs) against antimicrobial resistance.

🔗 inarmor-project.eu

#EUFunded #HaDEA #INARMOR #HorizonEurope #HostDirectedTherapy
September 22, 2026 at 4:02 PM
in-armor.bsky.social
🧬 Why is this a major step?
By reinforcing the host’s innate immune system rather than directly targeting bacteria, we aim to tackle antimicrobial resistance (#AMR) without contributing to drug resistance.

Discover more 🌐 inarmor-project.eu

#EUfunded #HaDEA #HostDirectedTherapy #DrugDevelopment
In Armor Project - In Armor Project
THERAPEUTIC EPIGENETIC ENHANCEMENT OF INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESISTANCE THERAPEUTIC EPIGENETIC ENHANCEMENT OF INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESISTANCE More infoThe ProblemAntimicrobial resistance (AMR) and multi-drug resistance, whereby pathogens evolve to resist antibiotic drugs, is designated by the World Health Organization (WHO) as a top 10 health threat of our time. AMR
inarmor-project.eu
September 23, 2026 at 8:20 AM
onehealthadv.bsky.social
🔬 New study explores the role of arginine metabolism in TB infection, highlighting arginine supplementation as a promising adjunctive therapy to enhance immunity and promote lung repair. 📚✨
#TBResearch #HostDirectedTherapy
👉https://onehealthadv.biomedcentral.com/articles/10.1186/s44280-025-00070-6
April 9, 2025 at 1:31 AM
johannesnemeth.bsky.social
This work was a major collaborative effort across Zurich 🇨🇭 and Seattle 🇺🇸.
We’re excited about what it means for the future of TB immunotherapy—and for understanding immune evasion across diseases. #TB #cMyc #Macrophages #HostDirectedTherapy
September 12, 2025 at 6:28 AM
ijaa-isac.bsky.social
Can phages, probiotic strains & host‑directed therapies reshape our fight against AMR? 🦠
👀 Check them out in the latest research: www.sciencedirect.com/journal/inte...

#AMR #InfectiousDiseases #PhageTherapy #Antimicrobials #HostDirectedTherapy

@isacworld.bsky.social
International Journal of Antimicrobial Agents | Vol 67, Issue 3, March 2026 | ScienceDirect.com by Elsevier
Read the latest articles of International Journal of Antimicrobial Agents at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
www.sciencedirect.com
March 24, 2026 at 9:43 PM